Volume 12 - Issue 4 - April, 2015

<p>Interview by Jennifer Ford</p>

The multicenter randomized controlled IN.PACT DEEP trial compared paclitaxel-coated balloons with uncoated balloons and failed to show benefit for the drug-eluting balloon. | Read More

<div>
<div>
<div>
<div>
<p>Interview by Jennifer Ford&nbsp;</p>
</div>
</div>
</div>
</div>

Peter Schneider, MD, describes results from the European and US arms of the IN.PACT SFA trial, which evaluated safety and efficacy of the In.Pact Admiral drug-eluting balloon compared to plain balloon angioplasty in the superficial femoral artery. | Read More

<div>
<div>
<div>
<div>
<p>Shabnam Rashid, BSc, MBChB; Chris Bishwanauth Sawh, MBBS; Dwayne Gavin Conway, MB ChB, MD<br />
From Leeds Teaching Hospital, Leeds, West Yorkshire; Sheffield Teaching Hospital, Sheffield, South Yorkshire; and Pinderfields Hospital, Wakefield, West Yorkshire, United Kingdom.&nbsp;</p>
</div>
</div>
</div>
</div>

The authors report the case of a 56-year-old male who had embolism of a fully deployed stent from the right coronary ostium to his brachial artery during percutaneous coronary intervention. | Read More

<p>Mark J. Alberts, MD<sup>1</sup>; Laurie Paletz, BSN, PHN, RN-BC<sup>2</sup>; Michael Wong, JD<sup>3</sup>&nbsp;,&nbsp;From the <sup>1</sup>Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center; <sup>2</sup>Stroke Program, Cedars-Sinai Medical Center; and <sup>3</sup>Physician-Patient Alliance for Health &amp; Safety</p>

<p>&nbsp;</p>

New Stroke VTE Safety Recommendations provide 4 key steps to help prevent deep vein thrombosis and pulmonary embolism in stroke patients. | Read More

<p>See-Wei Low, MD<sup>1</sup>; Kapildeo Lotun, MD<sup>2</sup>; Kwan Seung Lee, MD<sup>2 ,</sup>From the <sup>1</sup>University of Arizona and <sup>2</sup>Section of Vascular Medicine, Sarver Heart Center,<br />
University of Arizona, Tucson, Arizona.</p>

The authors describe a case of a patient with iliofemoral thrombosis precipitated by May-Thurner Syndrome with duplicate inferior vena cava, heterozygous mutation of factor V Leiden, and describe a successful treatment approach. | Read More

<div>
<div>
<div>
<div>
<p>Craig Walker, MD,&nbsp;Clinical Editor,&nbsp;Interventional Cardiologist,&nbsp;Founder, President, and&nbsp;Medical Director, &nbsp;Cardiovascular Institute of the South Clinical Professor of Medicine,&nbsp;Tulane University School of Medicine Louisiana State University School<br />
of Medicine&nbsp;</p>
</div>
</div>
</div>
</div>

All vascular clinicians must consider venocompressive syndromes in their differential diagnosis of venous disorders. | Read More